- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06016712
The Effect of Labor on Intraocular Pressure Fluctuation in Healthy Eyes (ELIPFHE)
March 16, 2025 updated by: Jan Zapletal, Faculty Hospital Kralovske Vinohrady
Glaucoma is a multifactorial disease, an important risk factor of which is increased intraocular pressure.
Fluctuations in intraocular pressure are often associated with vaginal birth, although intraocular pressure during active pushing during stage II has never been measured..
The study will be conducted on a group of patients with healthy eyes on patients who have completely fine vision or have a small refractive error and are accustomed to wearing contact lenses.
The measurement of intraocular pressure itself will be carried out using SENSIMED Triggerfish contact lenses, which measure pressure every 5 minutes for 30s.
This period roughly corresponds to the duration of 1-2 contractions.
Inclusion in the study will be offered to patients in the 35th to 37th week of pregnancy.
Prior to measurement patients will be sent to an eye clinic for a detailed examination of both eyes, which includes measuring intraocular pressure.
Subsequently, pregnancy checks will take place according to the standard scheme and in the standard scope.
At the onset of uterine contractions, an ophthalmologic consultant will be called, which will measure intraocular pressure between contractions using the Tonopen device and put on SENSIMED Trigerfish contact lenses in combination with a local anesthetic.
The patient will have these lenses until the end of the third stage of labor, i.e. 2 hours after the birth, when the lenses are removed.
In the second stage of labor, continuous monitoring by a cardiotocograph will take place.
Subsequently, the obtained data from the cardiotocograph and contact lenses will be evaluated and compared by a team of ophthalmologists and gynecologists, where the investigators will be able to assess the individual fluctuations in intraocular pressure depending on the individual contractions.
The aim of the study is to demonstrate or disprove the risks to the glaucoma patient due to increased intraocular pressure during active pushing in combination with uterine contraction.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Glaucoma is a multifactorial disease, an important risk factor of which is increased intraocular pressure.
Fluctuations in intraocular pressure are often associated with vaginal birth, although intraocular pressure during active pushing during stage II has never been measured.
The study will be conducted on a group of patients with healthy eyes on patients who have completely fine vision or have a small refractive error and are accustomed to wearing contact lenses.
The measurement of intraocular pressure itself will be carried out using SENSIMED Triggerfish contact lenses, which measure pressure every 5 minutes for 30s.
This period roughly corresponds to the duration of 1-2 contractions.
Inclusion in the study will be offered to patients in the 35th to 37th week of pregnancy.Prior to measurement patients will be sent to an eye clinic for a detailed examination of both eyes, which includes measuring intraocular pressure.
Subsequently, pregnancy checks will take place according to the standard scheme and in the standard scope.
At the onset of uterine contractions, an ophthalmologic consultant will be called, which will measure intraocular pressure between contractions using the Tonopen device and put on SENSIMED Trigerfish contact lenses in combination with a local anesthetic.
The patient will have these lenses until the end of the third stage of labor, i.e. 2 hours after the birth, when the lenses are removed.
In the second stage of labor, continuous monitoring by a cardiotocograph will take place.
Subsequently, the obtained data from the cardiotocograph and contact lenses will be evaluated and compared by a team of ophthalmologists and gynecologists, where the investigators will be able to assess the individual fluctuations in intraocular pressure depending on the individual contractions.
The aim of the study is to demonstrate or disprove the risks to the glaucoma patient due to increased intraocular pressure during active pushing in combination with uterine contraction.
Study Type
Interventional
Enrollment (Estimated)
9
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Jan Zapletal, MD
- Phone Number: +420607882602
- Email: honza.zaple@seznam.cz
Study Contact Backup
- Name: Alina Dana Baxant, MD
- Phone Number: +420734395155
- Email: alinadana.baxant@fnkv.cz
Study Locations
-
-
-
Praha, Czechia, 11000
- Recruiting
- Faculty Hospital Kralovske Vinohrady
-
Contact:
- Jan Zapletal, MD
- Phone Number: +420607882602
- Email: honza.zaple@seznam.cz
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- physiological pregnancy
- primiparous women
Exclusion Criteria:
- multiparous women
- pathological pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Participant
SENSIMED Triggerfish lenses will be applied on this Arm and Intraocular pressure during active phase of delivery will be measured
|
Contact lenses used for measuring intraocular pressure.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fluctuation of Intraocular pressure
Time Frame: From start of regular contractions for the length of 24 hours (at least 2 hours after delivery if patient complies about the lenses)
|
Investigators will use SENSIMED Triggerfish Lenses - contact lenses used for measuring intraocular pressure.
Lenses are sending detailed description of intraocular pressure in regular time range.
Measurements are then send to the software which compares all collected data.
|
From start of regular contractions for the length of 24 hours (at least 2 hours after delivery if patient complies about the lenses)
|
|
Rate of Uterine contractions
Time Frame: Continuous CTG will be done during II phase of delivery and at least every 2 hours durins I phase of delivery
|
Cardiotocography will be used for measuring regular uterine activity.
Tocography will be used for evaluation of uterine activity compared to intraocular pressure
|
Continuous CTG will be done during II phase of delivery and at least every 2 hours durins I phase of delivery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Pavel Studeny, prof, MD, Ph.D., Fakultni nemocnice Kralovske Vinohrady
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 8, 2023
Primary Completion (Estimated)
December 31, 2025
Study Completion (Estimated)
December 31, 2025
Study Registration Dates
First Submitted
August 8, 2023
First Submitted That Met QC Criteria
August 23, 2023
First Posted (Actual)
August 30, 2023
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
March 16, 2025
Last Verified
March 1, 2025
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- EK-VP/55l012022
- Internal hospital grant (Other Grant/Funding Number: Fakultni Nemocnice Kralovske Vinohrady)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intraocular Pressure
-
Attikon HospitalRecruitingIntraocular PressureGreece
-
Icare Finland OyCompleted
-
Wake Forest University Health SciencesCompleted
-
Nidek Co. LTD.Completed
-
Topcon CorporationCompleted
-
Topcon Medical Systems, Inc.CompletedIntraocular PressureUnited States
-
Meir Medical CenterCompleted
-
Instituto de Olhos de GoianiaCompletedIntraocular PressureBrazil
Clinical Trials on SENSIMED Triggerfish Eye Lenses
-
Sensimed AGUniversity Hospital, GenevaTerminated
-
Sensimed AGPrivate practicioner, Dr Sunaric Mégevand; Orasis, AugenZentrum PajicTerminatedPigmentary Dispersion Syndrome | Pigmentary Glaucoma PatientsSwitzerland
-
Sensimed AGCompleted
-
Sensimed AGTerminatedPrimary Open-angle Glaucoma (POAG) PatientUnited States
-
Sensimed AGCompletedSleep Apnea, Obstructive | Primary Open-angle GlaucomaUnited States
-
Sensimed AGClinique MonchoisiTerminatedPrimary Open Angle GlaucomaSwitzerland
-
Sensimed AGCompleted
-
University Hospital, BordeauxCompletedOpen Angle Glaucoma With a Progressive Visual FieldFrance